Data Knights Acquisition (NASDAQ:DKDCA) & Absci (NASDAQ:ABSI) Critical Comparison

Data Knights Acquisition (NASDAQ:DKDCAGet Rating) and Absci (NASDAQ:ABSIGet Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Insider & Institutional Ownership

78.5% of Data Knights Acquisition shares are held by institutional investors. Comparatively, 47.6% of Absci shares are held by institutional investors. 23.1% of Data Knights Acquisition shares are held by insiders. Comparatively, 19.4% of Absci shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Data Knights Acquisition and Absci’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Data Knights Acquisition N/A N/A $340,000.00 $0.03 364.00
Absci $5.75 million 20.12 -$104.90 million ($1.16) -1.08

Data Knights Acquisition has higher earnings, but lower revenue than Absci. Absci is trading at a lower price-to-earnings ratio than Data Knights Acquisition, indicating that it is currently the more affordable of the two stocks.


This table compares Data Knights Acquisition and Absci’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Data Knights Acquisition N/A -4.45% 0.35%
Absci -1,825.37% -34.28% -29.50%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Data Knights Acquisition and Absci, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Data Knights Acquisition 0 0 0 0 N/A
Absci 1 0 5 0 2.67

Absci has a consensus target price of $9.00, suggesting a potential upside of 620.00%. Given Absci’s higher possible upside, analysts clearly believe Absci is more favorable than Data Knights Acquisition.

Volatility and Risk

Data Knights Acquisition has a beta of 0.02, indicating that its share price is 98% less volatile than the S&P 500. Comparatively, Absci has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.


Data Knights Acquisition beats Absci on 8 of the 12 factors compared between the two stocks.

About Data Knights Acquisition

(Get Rating)

Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.

About Absci

(Get Rating)

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Receive News & Ratings for Data Knights Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Data Knights Acquisition and related companies with's FREE daily email newsletter.